Rev. Rom de STOMATOLOGIE nr.1 - 2007.p65 - medica.ro
Rev. Rom de STOMATOLOGIE nr.1 - 2007.p65 - medica.ro
Rev. Rom de STOMATOLOGIE nr.1 - 2007.p65 - medica.ro
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REVISTA ROMÂNÅ DE <st<strong>ro</strong>ng>STOMATOLOGIE</st<strong>ro</strong>ng> – VOL. LIII, NR. 1, AN 2007<br />
The <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>velopment of new materials and techniques<br />
in <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>ntistry has required the practitioner to<br />
<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>velop new artistic skills. The restorative <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>ntist<br />
manipulates light, color, illusion, shape and form<br />
to create an esthetic outcome. We must take into<br />
consi<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>ration principles, materials, techniques and<br />
other clinical applications for successful esthetic<br />
treatment. We must <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>monstrate important concepts<br />
involving hue, values, ch<strong>ro</strong>ma, shading, the<br />
rehabilitation of facial contours, dimensions, relief,<br />
symmetry, natural aspects, parameters characteristic<br />
for natural teeth.<br />
The competition between biomaterials and<br />
technologies generated new methods of therapy<br />
achieved by releasing an optimal adaptation by<br />
respecting the conditions p<strong>ro</strong>per to the hygienic<br />
and p<strong>ro</strong>phylactic principle.<br />
Expertise in these area differentiate ordinary<br />
<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>ntist f<strong>ro</strong>m one practicing a higher level of care<br />
and artistry.<br />
SINDROM SJÖGREN ªI LIMFOM MALIGN<br />
NONHODGKINIAN – EXPERIENºA<br />
ROMÂNEASCÅ<br />
Asist. Univ. Dr. Daniela Opri¿,<br />
ªef Lucr. Dr. Violeta Bojincå,<br />
ªef Lucr. Dr. Andra Bålånescu,<br />
Conf. Univ. Dr. Denisa Pre<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>¡eanu,<br />
P<strong>ro</strong>f. Univ. Dr. Ruxandra Ionescu<br />
Clinica <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> Medicinå Internå ¿i<br />
Reumatologie, Spitalul „Sf. Maria“,<br />
Centrul <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> Cercetare în Patologia ¿i<br />
Tratamentul Bolilor Sistemice Reumatismale<br />
Universitatea <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> Medicinå ¿i farmacie<br />
„Ca<strong>ro</strong>l Davila“, Bucure¿ti<br />
Premise<br />
Sind<strong>ro</strong>mul Sjögren (SS) este una dintre cele mai<br />
frecvente dar ¿i subdiagnosticate boli autoimune,<br />
afectând ap<strong>ro</strong>ximativ 1% din popula¡ie. ºinta principalå<br />
a acestei afec¡iuni este reprezentatå <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> ¡esutul<br />
exocrin care este infiltrat p<strong>ro</strong>gresiv cu limfocite,<br />
rezultatul fiind scå<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>rea secre¡iei glandulare.<br />
Cea mai <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> temut complica¡ie a SS este reprezentatå<br />
<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> posibilitatea <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>zvoltare a limfomului malign<br />
nonhodgkinian.<br />
Obiective<br />
Evaluarea caracteristicilor clinice ¿i paraclinice<br />
ale pacien¡ilor cu Sind<strong>ro</strong>m Sjögren care <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>zvoltå<br />
limfom malign.<br />
Metodå<br />
Am evaluat ret<strong>ro</strong>spectiv datele a 64 <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> pacien¡i<br />
(98% femei, cu vârstele între 32 ¿i 74 <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> ani, vârsta<br />
21<br />
medie <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> 52 ani) diagnostica¡i cu SS ¿i urmåri¡i în<br />
clinica noastrå între 1996 ¿i 2006. Pacien¡ii cu SS<br />
primar (18-35,3%) au fost diagnostica¡i conform<br />
Criteriilor Consensului Eu<strong>ro</strong>peano-American. Diagnosticul<br />
<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> limfom malign a fost confirmat histologic.<br />
Rezultate<br />
Patru pacien¡i, toate femei cu vârsta cuprinså<br />
între 54 ¿i 62 <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> ani, au <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>zvoltat limfom. Timpul<br />
mediu <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>zvoltare al acestuia a fost <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> 8,6 ani.<br />
Pacien¡ii prezentau xe<strong>ro</strong>stomie ¿i xe<strong>ro</strong>ftalmie<br />
severe, tumefac¡ie pa<strong>ro</strong>tidianå recurentå ¿i fenomen<br />
Raynaud. Douå dintre ele au prezentat manifeståri<br />
vasculitice ¿i splenomegalie. Toate aceste<br />
paciente au primit doze mari <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> corticoste<strong>ro</strong>izi ¿i<br />
imunosupresoare pe o duratå mai mare <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> 5 ani. Modificårile<br />
examenelor <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> laborator au fost urmåtoarele:<br />
100% sind<strong>ro</strong>m inflamator (VSH>80mm/h),<br />
66% crioglobulinemie ¿i hipocomplementemie.<br />
Toate au prezentat nivele crescute ale Ac anti Ro/<br />
SS-A. Într-un caz a fost i<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>ntificatå negativarea<br />
factorului reumatoid anterior persistent pozitiv.<br />
Limfoamul a fost i<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>ntificat la nivel ganglionar (3 paciente)<br />
¿i la nivelul glan<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>lor salivare (o pacientå).<br />
Tipul histologic a fost – limfom cu celula B micå<br />
<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> zona marginalå. În ceea ce prive¿te evolu¡ia, 3<br />
pacien¡i au avut un råspuns foarte bun la radioterapie.<br />
O pacientå, al cårei diagnostic a fost stabilit<br />
în stadiul IIIB, a necesitat chimioterapie. La aceasta<br />
din urmå a fost i<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>ntificatå infec¡ie c<strong>ro</strong>nicå cu<br />
virusul Ebstein-Barr.<br />
Concluzii<br />
Subiec¡ii cu SS trebuie atent monitoriza¡i pentru<br />
<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>zvoltarea limfomului malign nonhodgkinian. La<br />
pacien¡ii evalua¡i au putut fii i<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>ntifica¡i factori<br />
predictivi clinici ¿i paraclinici cita¡i în literatura<br />
<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> specialitate. Dozele mari <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng> imunosupresoare<br />
pot avea un posibil <strong>ro</strong>l în <st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>zvoltarea malignitå¡ii.<br />
SJÖGREN’S SYNDROME AND NON-<br />
HODGKIN’S LYMPHOMA – ROMANIAN<br />
EXPERIENCE<br />
Daniela Opri¿, MD, Assist. P<strong>ro</strong>f.<br />
Violeta Bojincå, MD, Assist. P<strong>ro</strong>f.<br />
Andra Bålånescu, MD, Assist. P<strong>ro</strong>f.<br />
Denisa Pre<st<strong>ro</strong>ng>de</st<strong>ro</strong>ng>¡eanu, MD, PhD<br />
Ruxandra Ionescu, MD, PhD<br />
Department of Internal Medicine and<br />
Rheumatology, „Sf. Maria“ Hospital<br />
Research Center of Rheumatic Diseases<br />
(RCRD)